Bulletin
Investor Alert

New York Markets After Hours

Market Pulse Archives

Oct. 27, 2021, 8:48 a.m. EDT

Novavax is seeking authorization in the U.K. for its COVID-19 vaccine

new
Watchlist Relevance
LEARN MORE

Want to see how this story relates to your watchlist?

Just add items to create a watchlist now:

  • X
    Novavax Inc. (NVAX)
  • X
    BioNTech SE ADR (BNTX)
  • X
    Pfizer Inc. (PFE)

or Cancel Already have a watchlist? Log In

By Jaimy Lee

Shares of Novavax Inc. /zigman2/quotes/202614340/composite NVAX -11.60% jumped 8.0% in premarket trading on Wednesday after the company said it began submitting its experimental COVID-19 vaccine for authorization in the U.K. Novavax's vaccine candidate is protein-based, meaning it's a different type of vaccine than the mRNA shots developed by BioNTech SE /zigman2/quotes/214419716/composite BNTX -18.67% /Pfizer Inc. /zigman2/quotes/202877789/composite PFE -5.14% and Moderna Inc. /zigman2/quotes/205619834/composite MRNA -13.49% or the ChAdOx1 technology used in the AstraZeneca /zigman2/quotes/200304487/composite AZN +2.18% shots. Novavax's vaccine came out of clinical trials in the U.K. with an overall efficacy rate of 89.7%. The company plans to submit its vaccine candidate to U.S. regulators by the end of the year. Novavax's stock is up 21.0% for the year, while the S&P 500 /zigman2/quotes/210599714/realtime SPX +1.17% has gained 21.8%.

/zigman2/quotes/202614340/composite
US : U.S.: Nasdaq
$ 141.86
-18.62 -11.60%
Volume: 5.86M
Dec. 6, 2021 4:00p
P/E Ratio
N/A
Dividend Yield
N/A
Market Cap
$12.13 billion
Rev. per Employee
$601,262
loading...
/zigman2/quotes/214419716/composite
US : U.S.: Nasdaq
$ 279.83
-64.23 -18.67%
Volume: 6.77M
Dec. 6, 2021 4:00p
P/E Ratio
8.08
Dividend Yield
N/A
Market Cap
$83.44 billion
Rev. per Employee
$283,276
loading...
/zigman2/quotes/202877789/composite
US : U.S.: NYSE
$ 51.48
-2.79 -5.14%
Volume: 53.67M
Dec. 6, 2021 4:02p
P/E Ratio
15.28
Dividend Yield
3.03%
Market Cap
$304.61 billion
Rev. per Employee
$533,860
loading...
/zigman2/quotes/205619834/composite
US : U.S.: Nasdaq
$ 265.33
-41.39 -13.49%
Volume: 19.77M
Dec. 6, 2021 4:00p
P/E Ratio
16.30
Dividend Yield
N/A
Market Cap
$124.36 billion
Rev. per Employee
$617,996
loading...
/zigman2/quotes/200304487/composite
US : U.S.: Nasdaq
$ 55.41
+1.18 +2.18%
Volume: 5.21M
Dec. 6, 2021 4:00p
P/E Ratio
87.45
Dividend Yield
2.47%
Market Cap
$167.75 billion
Rev. per Employee
$362,602
loading...
/zigman2/quotes/210599714/realtime
US : S&P US
4,591.67
+53.24 +1.17%
Volume: 2.58B
Dec. 6, 2021 5:09p
loading...

This Story has 0 Comments
Be the first to comment
More News In
Industries

Story Conversation

Commenting FAQs »

Partner Center

Link to MarketWatch's Slice.